XML 98 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Data
 3 Months Ended
Dec. 27, 2013
Segment Reporting [Abstract]  
Segment Data
19.
Segment Data
Selected information by business segment was as follows:

Three Months Ended

December 27,
2013

December 28,
2012
Net sales:



Specialty Pharmaceuticals
$
309.5


$
260.2

Global Medical Imaging
218.6


229.7

Net sales of operating segments (1)
528.1


489.9

Other (2)
12.1


14.1

Net sales
$
540.2


$
504.0

Operating income:



Specialty Pharmaceuticals
$
113.0


$
35.0

Global Medical Imaging
4.4


49.1

Segment operating income
117.4


84.1

Unallocated amounts:





Corporate and allocated expenses (3)          
(25.2
)

(25.4
)
Intangible asset amortization
(8.8
)

(8.9
)
Restructuring and related charges, net (4)
(8.1
)

(1.0
)
Separation costs
(2.2
)

(12.0
)
Operating income
$
73.1

 
$
36.8

(1)
Amounts represent sales to external customers.
(2)
Represents products that were sold to Covidien, our former parent company, which is discussed in Note 14.
(3)
Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
(4)
Includes restructuring-related accelerated depreciation of $0.1 million and $0.8 million for the three months ended December 27, 2013 and December 28, 2012, respectively.